View in EDS HTML Full Text PDF Full Text

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Saved in:
Bibliographic Details
Title: Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
Authors: Simon F; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Ligtvoet R; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Fürstenau M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Langerbeins P; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Fink AM; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., von Tresckow J; Department of Hematology, Oncology and Palliative Care, Katholisches Klinikum Bochum, Ruhr University Bochum, Bochum, Germany., Cramer P; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Kutsch N; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Goede V; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Poulsen CB; Department of hematology, Zealand University Hospital, Roskilde, Denmark., Illmer T; Hematology Private Practice, Dresden, Germany., Müller L; Study Centrum Unter Ems, Practice for Oncology and Hematology, Leer, Germany., Vehling-Kaiser U; Outpatient Clinic, Landshut, Germany., Eckart M; Onkologische Schwerpunktpraxis Erlangen, Erlangen, Germany., Staber P; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria., Tadmor T; Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Juliusson G; Department of Hematology, Skåne University Hospital, Lund, Sweden., Thornton P; Department of Haematology, Beaumont Hospital, Dublin, Ireland., Sivcheva L; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria., Loscertales J; Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain., Jentsch-Ullrich K; Gemeinschaftspraxis für Hämatologie und Onkologie, Magdeburg, Germany., Hebart H; Department of Internal Medicine, Hematology and Oncology, Mutlangen, Germany., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Tausch E; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Schneider C; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Stilgenbauer S; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Kater AP; Department of Hematology and Cancer Center Amsterdam, Amsterdam, Netherlands., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Fischer K; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Robrecht S; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Hallek M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Eichhorst B; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Al-Sawaf O; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jun; Vol. 67 (7), pp. 1620-1626. Date of Electronic Publication: 2026 Mar 17.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41841194
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Simon+F%22">Simon F</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Ligtvoet+R%22">Ligtvoet R</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Fürstenau+M%22">Fürstenau M</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Langerbeins+P%22">Langerbeins P</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Fink+AM%22">Fink AM</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22von+Tresckow+J%22">von Tresckow J</searchLink>; Department of Hematology, Oncology and Palliative Care, Katholisches Klinikum Bochum, Ruhr University Bochum, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Cramer+P%22">Cramer P</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Kutsch+N%22">Kutsch N</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Goede+V%22">Goede V</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Poulsen+CB%22">Poulsen CB</searchLink>; Department of hematology, Zealand University Hospital, Roskilde, Denmark.<br /><searchLink fieldCode="AU" term="%22Illmer+T%22">Illmer T</searchLink>; Hematology Private Practice, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+L%22">Müller L</searchLink>; Study Centrum Unter Ems, Practice for Oncology and Hematology, Leer, Germany.<br /><searchLink fieldCode="AU" term="%22Vehling-Kaiser+U%22">Vehling-Kaiser U</searchLink>; Outpatient Clinic, Landshut, Germany.<br /><searchLink fieldCode="AU" term="%22Eckart+M%22">Eckart M</searchLink>; Onkologische Schwerpunktpraxis Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Staber+P%22">Staber P</searchLink>; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Tadmor+T%22">Tadmor T</searchLink>; Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Gregor+M%22">Gregor M</searchLink>; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Juliusson+G%22">Juliusson G</searchLink>; Department of Hematology, Skåne University Hospital, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Thornton+P%22">Thornton P</searchLink>; Department of Haematology, Beaumont Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Sivcheva+L%22">Sivcheva L</searchLink>; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Loscertales+J%22">Loscertales J</searchLink>; Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Jentsch-Ullrich+K%22">Jentsch-Ullrich K</searchLink>; Gemeinschaftspraxis für Hämatologie und Onkologie, Magdeburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hebart+H%22">Hebart H</searchLink>; Department of Internal Medicine, Hematology and Oncology, Mutlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Levin+MD%22">Levin MD</searchLink>; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22da+Cunha-Bang+C%22">da Cunha-Bang C</searchLink>; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Tausch+E%22">Tausch E</searchLink>; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Stilgenbauer+S%22">Stilgenbauer S</searchLink>; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Kater+AP%22">Kater AP</searchLink>; Department of Hematology and Cancer Center Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Niemann+CU%22">Niemann CU</searchLink>; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Fischer+K%22">Fischer K</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Robrecht+S%22">Robrecht S</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hallek+M%22">Hallek M</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Eichhorst+B%22">Eichhorst B</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Al-Sawaf+O%22">Al-Sawaf O</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2026 Jun; Vol. 67 (7), pp. 1620-1626. <i>Date of Electronic Publication: </i>2026 Mar 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41841194
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2026.2634939
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1620
    Titles:
      – TitleFull: Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Simon F
      – PersonEntity:
          Name:
            NameFull: Ligtvoet R
      – PersonEntity:
          Name:
            NameFull: Fürstenau M
      – PersonEntity:
          Name:
            NameFull: Langerbeins P
      – PersonEntity:
          Name:
            NameFull: Fink AM
      – PersonEntity:
          Name:
            NameFull: von Tresckow J
      – PersonEntity:
          Name:
            NameFull: Cramer P
      – PersonEntity:
          Name:
            NameFull: Kutsch N
      – PersonEntity:
          Name:
            NameFull: Goede V
      – PersonEntity:
          Name:
            NameFull: Poulsen CB
      – PersonEntity:
          Name:
            NameFull: Illmer T
      – PersonEntity:
          Name:
            NameFull: Müller L
      – PersonEntity:
          Name:
            NameFull: Vehling-Kaiser U
      – PersonEntity:
          Name:
            NameFull: Eckart M
      – PersonEntity:
          Name:
            NameFull: Staber P
      – PersonEntity:
          Name:
            NameFull: Tadmor T
      – PersonEntity:
          Name:
            NameFull: Gregor M
      – PersonEntity:
          Name:
            NameFull: Juliusson G
      – PersonEntity:
          Name:
            NameFull: Thornton P
      – PersonEntity:
          Name:
            NameFull: Sivcheva L
      – PersonEntity:
          Name:
            NameFull: Loscertales J
      – PersonEntity:
          Name:
            NameFull: Jentsch-Ullrich K
      – PersonEntity:
          Name:
            NameFull: Hebart H
      – PersonEntity:
          Name:
            NameFull: Levin MD
      – PersonEntity:
          Name:
            NameFull: da Cunha-Bang C
      – PersonEntity:
          Name:
            NameFull: Tausch E
      – PersonEntity:
          Name:
            NameFull: Schneider C
      – PersonEntity:
          Name:
            NameFull: Stilgenbauer S
      – PersonEntity:
          Name:
            NameFull: Kater AP
      – PersonEntity:
          Name:
            NameFull: Niemann CU
      – PersonEntity:
          Name:
            NameFull: Fischer K
      – PersonEntity:
          Name:
            NameFull: Robrecht S
      – PersonEntity:
          Name:
            NameFull: Hallek M
      – PersonEntity:
          Name:
            NameFull: Eichhorst B
      – PersonEntity:
          Name:
            NameFull: Al-Sawaf O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1